Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
logoRelationalStocks.com
STOCK TICKER:
Intercept Pharmaceuticals, Inc. - Common Stock   (ticker: ICPT)
Quote:Intercept Pharmaceuticals Inc.(ICPT) ICPT Quotes on: Yahoo | Google
85.67
1.56 (1.855%)
5 day's Perf: 22.13%
1 Month Perf: 21.15%
3 Month Perf: 27.12%
YTD Perf: 21.15%
1 Year Perf: 9.78%
Stock chart
Useful Quick Links for ICPT
Financial Key Date: Yahoo
Option Prices: MarketWatch
Technical Opinion: Barchar.com
Technical Charts: StockCharts.com
Analyst & Estimates: Reuters
Ratings: TheStreet.com
SEC Filings: EDGAR Online
Message Boards: Yahoo | TheLion
Insiders' Indicator :          Buy          (Click Here For Details)
INSIDERS' Score: 75
0 100 75
BuySell
Latest 1 month: 0 0
Latest 6 Months: 798,045 0
52 Weeks: 798,045 51,226
Gurus' Indicator :          Hold          (Click Here For Details)
GURUS' Score: 40
0 100 40
Current Holdings: 212,982
Previous Holdings: 227,152
Change: 6.24%
Institutions' Indicator :          Buy          (Click Here For Details)
INSTITUTIONS' Score: 60
0 100 60
Current Holdings: 20,783,534
Previous Holdings: 18,286,185
Change: 13.66%
News And Links For The Group (Contribute a link)
[ICPT]   An Integrated BioSci Research On Madrigal: What The Stellar Data Reporting For MGL-3196 Foretells  (Seeking Alpha)   7-Jun-18 07:12
[ICPT]   Madrigal Soars 144% On NASH Results, Is There Room To Run Higher?  (Seeking Alpha)   1-Jun-18 00:38
[ICPT]   Novartis In Liver Diseases NASH And PBC: A Look At The Bright Side  (Seeking Alpha)   17-May-18 14:35
[ICPT]   Your Daily Pharma Scoop: Galectin Phase 3 Trial, Acer NDA, Chiasma SPA Amendments  (Seeking Alpha)   15-May-18 10:00
[ICPT]   Free Research Reports on These Biotech Stocks -- Exelixis, INSYS Therapeutics, Intellia Therapeutics, and Intercept Pharma  (PR Newswire)   2-May-18 06:35
[ICPT]   CymaBay Therapeutics Pushes Itself To The Next Stage Against Rare Liver Disease  (Seeking Alpha)   12-Apr-18 00:50
[ICPT]   Biotech Analysis Central Pharma News: Novartis's Gene Therapy Catch, AstraZeneca's NASH Move, Clovis's Expanded Rubraca Market  (Seeking Alpha)   11-Apr-18 00:31
[ICPT]   BioSci Rounds Report: Strong Data Catapulted Spectrum While Intercept Is Poised For Growth  (Seeking Alpha)   10-Apr-18 23:25
[ICPT]   Pre-Market Technical Scan on Biotech Equities -- INSYS Therapeutics, Intellia Therapeutics, Intercept Pharma, and Intra-Cellular Therapies  (PR Newswire)   2-Apr-18 07:05
[ICPT]   Immuron Achieves Positive Phase 2 NASH Results, Presents Itself As A Good Buy  (Seeking Alpha)   13-Mar-18 11:54
[ICPT]   The Storm Around Intercept Is Settled. Here Is How To Trade The Stock  (Seeking Alpha)   2-Mar-18 11:41
[ICPT]   Galmed Tumbles On Phase 2 NASH Data, But There Is More To The Story Than Meets The Eye  (Seeking Alpha)   16-Feb-18 00:38
[ICPT]   Your Daily Pharma Scoop: Progenics Azerda Update, Atara Gets FDA Clearance For Phase 3 Trial, Avadel Provides Update  (Seeking Alpha)   31-Dec-17 09:42
[ICPT]   Your Daily Pharma Scoop: Intercept Updates On NASH Trial, GW Pharmaceuticals Provides Regulatory Update, Odonate Initiates Trial  (Seeking Alpha)   30-Dec-17 13:35
[ICPT]   Your Daily Pharma Scoop: Biogen Setback, Ironwood Commences Trial, Vtv Signs 2 Deals  (Seeking Alpha)   23-Dec-17 11:37
[ICPT]   Notable BioSci Mover - October 6, 2017 Report  (Seeking Alpha)   7-Dec-17 10:11
[ICPT]   Your Daily Pharma Scoop: Gilead's Potential, Celgene CAR-T Candidate, Cellectar Soars  (Seeking Alpha)   7-Dec-17 08:00
[ICPT]   NASH Stocks Brace For Shockwaves From Galectin Therapeutics Trial Results  (Seeking Alpha)   4-Dec-17 15:00
[ICPT]   Bitcoin vs. Biotech: Which Is the Smarter Investment?  (Motley Fool)   8-Oct-17 08:18
[ICPT]   Why Intercept Pharmaceuticals, Tronox, and MobileIron Jumped Today  (Motley Fool)   5-Oct-17 16:30
==>More News
*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*